Lv1
40 积分 2024-07-28 加入
A novel framework for lung cancer classification using lightweight convolutional neural networks and ridge extreme learning machine model with SHapley Additive exPlanations (SHAP)
9个月前
已完结
Phase II study to evaluate surufatinib in patients with osteosarcoma and soft tissue sarcoma that has failed standard chemotherapy: Updated analysis
9个月前
已完结
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
9个月前
已完结
皖公网安备34019202002308
